Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Olander Clinical Consulting K/S
K/S
Active
CVR 35860177
Skibsegen 70, 3070
Snekkersten
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2014 · 12 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Olander Clinical Consulting K/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
EBITDA
DKK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
2.099
2.004
1.883
1.919
1.798
Staff expenses
-0
-0
-0
-0
-0
EBITDA
2.099
2.004
1.883
1.919
1.798
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
2.099
2.004
1.883
1.919
1.798
Net financials
-42
1
0
-39
-39
Profit before tax
2.058
2.005
1.883
1.880
1.759
Tax
-0
-0
-0
-0
-0
Net profit
2.058
2.005
1.883
1.880
1.759
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
699
1.007
934
818
860
Equity
303
555
622
621
687
Long-term debt
0
0
0
0
0
Short-term debt
395
452
312
197
173
Total debt
395
452
312
197
173
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100,0 %
This company
2021
2025
Equity ratio
43,4 %
This company
38,2 %
Market median
This company
Market median
14% above market
2021
2025
Return on equity
678,5 %
This company
18,4 %
Market median
This company
Market median
>999% above market
2021
2025
Net profit margin (of gross profit)
98,0 %
This company
2021
2025
Asset turnover (of gross profit)
3,01×
This company
2021
2025
Debt / equity
1,30×
This company
0,62×
Market median
This company
Market median
110% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Olander Clinical Consulting K/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
